Clinical Trials Browser

Phase 1 × Keratosis, Actinic × Celecoxib × Clear all

NCT03643744 2024-12-19

Photodynamic Therapy-Induced Immune Modulation: Part III

Phase 1 Terminated

12 enrolled 9 charts

Keratosis, Actinic